βA1-crystallin regulates glucose metabolism and mitochondrial function in mouse retinal astrocytes by modulating PTP1B activity
Sayan Ghosh,Haitao Liu,Meysam Yazdankhah,Nadezda Stepicheva,Peng Shang,Tanuja Vaidya,Stacey Hose,Urvi Gupta,Michael Joseph Calderon,Ming-Wen Hu,Archana Padmanabhan Nair,Joseph Weiss,Christopher S. Fitting,Imran A. Bhutto,Santosh Gopi Krishna Gadde,Naveen Kumar Naik,Chaitra Jaydev,Gerard A. Lutty,James T. Handa,Ashwath Jayagopal,Jiang Qian,José-Alain Sahel,Dhivyaa Rajasundaram,Yuri Sergeev,J. Samuel Zigler,Swaminathan Sethu,Simon Watkins,Arkasubhra Ghosh,Debasish Sinha
DOI: https://doi.org/10.1038/s42003-021-01763-5
IF: 6.548
2021-02-24
Communications Biology
Abstract:Abstract βA3/A1-crystallin, a lens protein that is also expressed in astrocytes, is produced as βA3 and βA1-crystallin isoforms by leaky ribosomal scanning. In a previous human proteome high-throughput array, we found that βA3/A1-crystallin interacts with protein tyrosine phosphatase 1B (PTP1B), a key regulator of glucose metabolism. This prompted us to explore possible roles of βA3/A1-crystallin in metabolism of retinal astrocytes. We found that βA1-crystallin acts as an uncompetitive inhibitor of PTP1B, but βA3-crystallin does not. Loss of βA1-crystallin in astrocytes triggers metabolic abnormalities and inflammation. In CRISPR/cas9 gene-edited βA1-knockdown (KD) mice, but not in βA3-knockout (KO) mice, the streptozotocin (STZ)-induced diabetic retinopathy (DR)-like phenotype is exacerbated. Here, we have identified βA1-crystallin as a regulator of PTP1B; loss of this regulation may be a new mechanism by which astrocytes contribute to DR. Interestingly, proliferative diabetic retinopathy (PDR) patients showed reduced βA1-crystallin and higher levels of PTP1B in the vitreous humor.
biology